Findhelp, the leading social care software company dedicated to connecting all people in need and the programs that serve them, and The LBJ School of Public Affairs at the University of Texas-Austin ...

Today in History for Jan. 29: ...

On Tuesday 11 September 2001, suicide attackers seized US passenger jets and crashed them into two New York skyscrapers, killing thousands of people. What unfolded that day has had profound ...

In a report released yesterday, Kerry Holford from Berenberg Bank maintained a Buy rating on Resolute Mining Limited (RMGGF – Research Report), ...

© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and ...

Notable medicines subject to price increases include Pfizer’s COVID-19 drug Paxlovid, Bristol Myers Squibb’s CAR-T therapies Abecma and Breyanzi and a clutch of vaccines from Sanofi ...

Pfizer gave Sangamo Therapeutics coal for Christmas, terminating a hemophilia A gene therapy pact to deprive the cash-strapped biotech of up to $220 million in milestones. Pfizer’s decision sent ...

SHPL was established in 2001 with Shanghai Pharma. SHPL’s consolidated net income attributable to HUTCHMED was $47.4m in 2023. The proceeds from the sale will be invested in advancing HUTCHMED’s core ...

Pfizer targets $4 billion in operational savings by 2024, improving margins and driving long-term profitability. PFE returned $7.1 billion via dividends in 9M-24, while reducing debt by $4.4 ...

Sangamo Therapeutics (NASDAQ:SGMO) lost nearly half of its market cap in early trading on Tuesday after Pfizer (NYSE:PFE) decided to end a collaboration with the company for its gene therapy ...

Strong performance in oncology and specialty products is fueling new growth at Pfizer. The stock's 6.3% dividend is well-funded, and management has just increased it. The bar is low for ...

Pfizer’s research partnership with Sangamo Therapeutics produced a hemophilia A gene therapy that reached FDA discussions about a regulatory submission. That’s as far as the alliance will go.